(Q37537154)

20 August 2017

1 reference

title

Role of guanylate cyclase modulators in decompensated heart failure (English)

1 reference

20 August 2017

0 references

4

Mihai Gheorghiade

1 reference

20 August 2017

Veselin Mitrovic

1

1 reference

PubMed ID

19568931

20 August 2017

Adrian F Hernandez

series ordinal

2

1 reference

PubMed ID

19568931

20 August 2017

Markus Meyer

series ordinal

3

1 reference

20 August 2017

1 December 2009

1 reference

20 August 2017

Heart Failure Reviews

1 reference

20 August 2017

14

1 reference

20 August 2017

4

1 reference

20 August 2017

309-319

1 reference

https://scigraph.springernature.com/pub.10.1007/s10741-009-9149-7

20 August 2017

0 references

cites work

Management of acute decompensated heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS10741-009-9149-7

Hemodynamic and renal effects of low-dose brain natriuretic peptide infusion in humans: a randomized, placebo-controlled crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-009-9149-7

Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-009-9149-7

Effects of the renal natriuretic peptide urodilatin (ularitide) in patients with decompensated chronic heart failure: a double-blind, placebo-controlled, ascending-dose trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-009-9149-7

Meeting report: cGMP matters

21 January 2018

1 reference

12 December 2020

Activation of the particulate and not the soluble guanylate cyclase leads to the inhibition of Ca2+ extrusion through localized elevation of cGMP.

1 reference

12 December 2020

Acute decompensated heart failure and the cardiorenal syndrome

1 reference

12 December 2020

Rational use of inotropic therapy in heart failure

1 reference

12 December 2020

Guanylyl cyclases and signaling by cyclic GMP.

1 reference

12 December 2020

Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).

1 reference

12 December 2020

Increased renal natriuretic peptide (urodilatin) excretion in heart failure patients

1 reference

12 December 2020

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

1 reference

12 December 2020

Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD).

1 reference

12 December 2020

A functional heme-binding site of soluble guanylyl cyclase requires intact N-termini of alpha 1 and beta 1 subunits.

1 reference

12 December 2020

cGMP signalling: from bench to bedside. Conference on cGMP generators, effectors and therapeutic implications

1 reference

12 December 2020

Soluble guanylate cyclase: not a dull enzyme.

1 reference

12 December 2020

Nitrosative stress and pharmacological modulation of heart failure

1 reference

12 December 2020

Atrial natriuretic factor: Its (patho)physiological significance in humans

1 reference

12 December 2020

Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels

1 reference

12 December 2020

Pharmacokinetics, pharmacodynamics, tolerability, and safety of the soluble guanylate cyclase activator cinaciguat (BAY 58-2667) in healthy male volunteers

1 reference

12 December 2020

Pharmacotherapy for systolic dysfunction: a review of randomized clinical trials

1 reference

12 December 2020

Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials

1 reference

12 December 2020

Effects of atrial natriuretic factor on the kidney and the renin-angiotensin-aldosterone system

1 reference

12 December 2020

Heart failure-related hospitalization in the U.S., 1979 to 2004.

1 reference

12 December 2020

Natriuretic peptides and therapeutic applications

1 reference

12 December 2020

Nitric oxide and peroxynitrite in health and disease

1 reference

12 December 2020

Cardiovascular, endocrine, and renal effects of urodilatin in normal humans

1 reference

12 December 2020

Haemodynamic and clinical effects of ularitide in decompensated heart failure

1 reference

12 December 2020

Heart failure: a state of brain natriuretic peptide deficiency or resistance or both!

1 reference

12 December 2020

Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure.

1 reference

12 December 2020

Identification of residues crucially involved in the binding of the heme moiety of soluble guanylate cyclase

1 reference

12 December 2020

NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential

1 reference

12 December 2020

Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.

1 reference

12 December 2020

Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man

1 reference

12 December 2020

Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial

1 reference

12 December 2020

Activation of soluble guanylate cyclase by NO-hemoproteins involves NO-heme exchange. Comparison of heme-containing and heme-deficient enzyme forms

1 reference

12 December 2020

The role of the natriuretic peptides in the cardiovascular system.

1 reference

12 December 2020

Renal effects of ularitide in patients with decompensated heart failure

1 reference

12 December 2020

Targeting heme-oxidized soluble guanylate cyclase in experimental heart failure.

1 reference

12 December 2020

A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators

1 reference

12 December 2020

Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery:the NAPA Trial.

1 reference

12 December 2020

Natriuretic peptide C receptor signalling in the heart and vasculature

1 reference

12 December 2020

NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle

1 reference

12 December 2020

Metabolism and action of urodilatin infusion in healthy volunteers

1 reference

12 December 2020

Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group.

1 reference

12 December 2020

Haemodynamic and renal effects of urodilatin in healthy volunteers

1 reference

12 December 2020

Diuretics for the treatment of acute decompensated heart failure

1 reference

12 December 2020

Autocrine and paracrine actions of natriuretic peptides in the heart

1 reference

12 December 2020

The prognostic importance of different definitions of worsening renal function in congestive heart failure

1 reference

12 December 2020

Mechanisms of nitric oxide independent activation of soluble guanylyl cyclase

1 reference

12 December 2020

In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).

1 reference

12 December 2020

Differential effects of soluble and particulate guanylyl cyclase on Ca(2+) sensitivity in airway smooth muscle

1 reference

12 December 2020

Differential effects of cGMP produced by soluble and particulate guanylyl cyclase on mouse ventricular myocytes

1 reference

12 December 2020

NO- and haem-independent soluble guanylate cyclase activators

1 reference

12 December 2020

Renal effects of brain natriuretic peptide in patients with congestive heart failure.

1 reference

12 December 2020

Comparison of vessel dilator and long-acting natriuretic peptide in the treatment of congestive heart failure

1 reference

12 December 2020

Prevention and reversal of nitrate tolerance in patients with congestive heart failure

1 reference

12 December 2020

Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial

1 reference

12 December 2020

Acute decompensated heart failure: a contemporary approach to pharmacotherapeutic management

1 reference

12 December 2020

Modulation of cGMP in heart failure: a new therapeutic paradigm

1 reference

12 December 2020

Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine

1 reference

12 December 2020

Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure

1 reference

12 December 2020

Urodilatin is involved in sodium homeostasis and exerts sodium-state-dependent natriuretic and diuretic effects

1 reference

12 December 2020

10.1007/S10741-009-9149-7

Identifiers

DOI

1 reference

20 August 2017

1 reference

PubMed ID

19568931